These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37331118)

  • 1. Polygenic risk scores and risk stratification in deep vein thrombosis.
    Lo Faro V; Johansson T; Höglund J; Hadizadeh F; Johansson Å
    Thromb Res; 2023 Aug; 228():151-162. PubMed ID: 37331118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes.
    de Haan HG; van Hylckama Vlieg A; Lotta LA; Gorski MM; Bucciarelli P; Martinelli I; Baglin TP; Peyvandi F; Rosendaal FR;
    J Thromb Haemost; 2018 Dec; 16(12):2432-2441. PubMed ID: 30168256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of the factor V Leiden paradox.
    van Stralen KJ; Doggen CJ; Bezemer ID; Pomp ER; Lisman T; Rosendaal FR
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1872-7. PubMed ID: 18617648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden and the risk of venous thrombosis, myocardial infarction, and stroke: a case-control study in Venezuela.
    Pestana CI; Torres A; Blanco S; Rojas MJ; Méndez C; López JL; de Bosch NB; Porco A
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):537-42. PubMed ID: 19604111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of factor V leiden, MTHFR C677T and MTHFR A1298C polymorphisms in patients with deep vein thrombosis in Central Iran.
    Ehsani M; Imani A; Moravveji A
    Mol Biol Rep; 2018 Aug; 45(4):621-624. PubMed ID: 29855758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox.
    Hirmerova J; Seidlerova J; Subrt I
    QJM; 2014 Sep; 107(9):715-20. PubMed ID: 24633260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monogenic and Polygenic Contributions to QTc Prolongation in the Population.
    Nauffal V; Morrill VN; Jurgens SJ; Choi SH; Hall AW; Weng LC; Halford JL; Austin-Tse C; Haggerty CM; Harris SL; Wong EK; Alonso A; Arking DE; Benjamin EJ; Boerwinkle E; Min YI; Correa A; Fornwalt BK; Heckbert SR; ; Kooperberg C; Lin HJ; J F Loos R; Rice KM; Gupta N; Blackwell TW; Mitchell BD; Morrison AC; Psaty BM; Post WS; Redline S; Rehm HL; Rich SS; Rotter JI; Soliman EZ; Sotoodehnia N; Lunetta KL; Ellinor PT; Lubitz SA;
    Circulation; 2022 May; 145(20):1524-1533. PubMed ID: 35389749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis].
    Jastrzebska M; Bałszan-Kowalska I; Ciechanowicz A; Bińczak-Kuleta A; Falkowski A; Chełstowski K
    Pol Arch Med Wewn; 2003 Jun; 109(6):579-88. PubMed ID: 14567090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study.
    Emdin CA; Haas M; Ajmera V; Simon TG; Homburger J; Neben C; Jiang L; Wei WQ; Feng Q; Zhou A; Denny J; Corey K; Loomba R; Kathiresan S; Khera AV
    Gastroenterology; 2021 Apr; 160(5):1620-1633.e13. PubMed ID: 33310085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden paradox in a middle-aged Swedish population: A prospective study.
    Zöller B; Melander O; Svensson PJ; Engström G
    Vasc Med; 2018 Feb; 23(1):52-59. PubMed ID: 29320959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large uncertainty in individual polygenic risk score estimation impacts PRS-based risk stratification.
    Ding Y; Hou K; Burch KS; Lapinska S; Privé F; Vilhjálmsson B; Sankararaman S; Pasaniuc B
    Nat Genet; 2022 Jan; 54(1):30-39. PubMed ID: 34931067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individuals with common diseases but with a low polygenic risk score could be prioritized for rare variant screening.
    Lu T; Zhou S; Wu H; Forgetta V; Greenwood CMT; Richards JB
    Genet Med; 2021 Mar; 23(3):508-515. PubMed ID: 33110269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
    Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G;
    Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of F11 polymorphism rs2289252 with deep vein thrombosis and related phenotypes in population of Latvia.
    Rovite V; Maurins U; Megnis K; Vaivade I; Pečulis R; Rits J; Prave S; Klovins J
    Thromb Res; 2014 Sep; 134(3):659-63. PubMed ID: 25091233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombus stability explains the factor V Leiden paradox: a mouse model.
    Shaya SA; Westrick RJ; Gross PL
    Blood Adv; 2019 Nov; 3(21):3375-3378. PubMed ID: 31698465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
    Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Elife; 2022 Jul; 11():. PubMed ID: 35801699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations.
    Stalbow LA; Preuss MH; Smit RAJ; Chami N; Bjørkhaug L; Aukrust I; Gloyn AL; Loos RJF
    Diabetologia; 2023 Jan; 66(1):116-126. PubMed ID: 36216889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.